Cost-effectiveness analysis of current therapies for melasma

被引：0
|
作者：
Piacquadio, DJ
Smith, S
机构：
[1] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA
[2] Therapeut Inc, San Diego, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.11.027
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P684
引用
收藏
页码：P175 / P175
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF CURRENT THERAPIES IN PRIMARY BILIARY CIRRHOSIS: A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE
    Pells, G.
    Jones, D.
    Vale, L.
    GUT, 2015, 64 : A195 - A195
  • [42] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Wong, Alyson W.
    Koo, John
    Ryerson, Christopher J.
    Sadatsafavi, Mohsen
    Chen, Wenjia
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [43] COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT OPTIONS FOR EOSINOPHILIC ESOPHAGITIS
    Hiramoto, Brent
    Muftah, Mayssan
    Flanagan, Ryan
    Shah, Eric D.
    Chan, Walter W.
    GASTROENTEROLOGY, 2023, 164 (06) : S348 - S348
  • [44] Cost-Effectiveness Analysis of Current Treatment Options for Eosinophilic Esophagitis
    Hiramoto, Brent
    Muftah, Mayssan
    Flanagan, Ryan
    Shah, Eric D.
    Chan, Walter W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 161 - 172
  • [45] Cost-effectiveness of current antiretroviral regimes
    Anis, AH
    Hogg, RS
    Wang, X
    Yip, B
    Guh, D
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    AIDS, 1998, 12 : S15 - S15
  • [46] PACS: current status and cost-effectiveness
    Arenson, RL
    EUROPEAN RADIOLOGY, 2000, 10 (Suppl 3) : S354 - S356
  • [47] PACS: current status and cost-effectiveness
    R. L. Arenson
    European Radiology, 2000, 10 : S354 - S356
  • [48] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF HEALTH-CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1988, 18 (01): : 1 - 9
  • [49] Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
    Bambha, K
    Kim, WR
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (06) : 519 - 526
  • [50] COST-EFFECTIVENESS ANALYSIS OF DRUG THERAPIES FOR DIABETES MELLITUS TYPE 2 IN CHILE
    Balmaceda, C.
    Abbott, T.
    Armijo, N.
    Zamorano, P.
    Espinoza, M. A.
    VALUE IN HEALTH, 2022, 25 (12) : S127 - S128
12345